Experimental Therapy Beats Back One Patient's Melanoma
Doctors used man's own immune system cells to eliminate the disease
Posted June 18, 2008
"It would be helpful to try to streamline the process," Yee said. "[Right now], we can only target a small fraction of patients. What we're looking for in the future is to streamline this process and decrease the time it takes to grow cells and to see if we can target other antigens. This is a proof of principle: Yes, we can use CD4+ clones."
More information
Visit the American Cancer Society for more on immunotherapy.
advertisement
